Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry

Tröbs M, Achenbach S, Nef HM, Gori T, Naber C, Neumann T, Richardt G, Schmermund A, Woehrle J, Zahn R, Hamm CW (2021)


Publication Type: Journal article

Publication year: 2021

Journal

DOI: 10.1002/ccd.29831

Abstract

Objectives To identify potential differences in 2-year outcome between patients who underwent coronary revascularization using bioresorbable vascular scafffolds (BVS) in stable coronary artery disease (CAD) and acute coronary syndromes (ACS).

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Tröbs, M., Achenbach, S., Nef, H.M., Gori, T., Naber, C., Neumann, T.,... Hamm, C.W. (2021). Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.29831

MLA:

Tröbs, Monique, et al. "Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry." Catheterization and Cardiovascular Interventions (2021).

BibTeX: Download